University of Vermont

College of Medicine

Vermont Cancer Center

Bio for Richard Albertini, MD, PhD

Richard Albertini, MD, PhD

Research Professor
Department of Pathology


Contact Information
E-mail: Richard.Albertini@uvm.edu
Office Location:
VCC Genetic Toxicology Lab, 32 No. Prospect Street, Pathology, Burlington, VT 05401

Education

1958-60 B.S.University of Wisconsin, Madison, WI
1959-63 M.D. University of Wisconsin, Medical School
1966-72 Ph.D. Department of Medical Genetics, University of Wisconsin, Madison, WI

Academic Appointments

2000-present, Research Professor, Pathology, University of Vermont
2000-present, Professor of Medicine, Emeritus, University of Vermont
1997-present, Adjunct Professor, Pathology, University of Vermont
1993-95, Director, Vermont Cancer Center
1992-93, Interim Director, Vermont Cancer Center
1990-91,Visiting Professor, Oncology, University of Wisconsin
1988-96, Unit Director, Medical Genetics, Department of Medicine
1986-88, Unit Director, Hematology/Oncology Unit, Department of Medicine, University of Vermont
1985-present, Adjunct Professor, Pediatrics, University of Vermont
1981-82, Visiting Professor of Medicine, University of Wisconsin
1980-present, Adjunct Professor, Medical Microbiology & Molecular Genetics, University of Vermont
1979-2000, Professor of Medicine, University of Vermont
1979-81, Director, Vermont Regional Genetics Center
1977-80, Associate Adjunct Professor, Medical Microbiology, University of Vermont
1974-79, Associate Professor of Medicine, University of Vermont
1973-75, Director, Program in Oncology, University of Vermont
1972-74, Unit Director, Medical Oncology, University of Vermont
1972-74, Assistant Professor of Medicine, University of Vermont
1970-72, Instructor in Medicine, University of Wisconsin, Madison, WI

Awards and Honors

Alpha Omega Alpha - University of Wisconsin, 1962
The Cora M. and Edward J. Van Liere Award, University of Wisconsin, 1963
The Alexander Hollaender Award of the Environmental Mutagen Society, 1990
St. George Medal - American Cancer Society, 1990

Publications

Sussman HE, Bauer MJ, Shi X, Judice SA, Albertini RJ, Walker VE (2001) Transplacental mutagenicity of N-ethyl-N-nitrosourea at the HPRT locus in T-lymphocytes of exposed B6C3F1 mice. Environ Mol Mutagen 38:30-37
Albertini RJ (2001) Developing sustainable studies on environmental health. Mutation Res 480-481:317-331
Albertini RJ, Sram RJ, Vacek PM, Lynch J, Nicklas JA, Boogaard PJ, Henderson RF, Swenberg JA, Tates AD, Ward Jr JB (2001) Biomarkers for assessing occupational exposures to 1,3-butadiene. Chem Biol Interact 135-136:429-453
Albertini RJ (2001) Validated biomarker responses influence medical surveillance of individuals exposed to genotoxic agents. Radiation Protection Dosimetry 97:47-54
Albertini RJ (2001) HPRT mutations in humans: Biomarkers for mechanistic studies. Mutation Res 489:1-16
Finette BA, Homans AC, Rivers J, Messier T, Albertini RJ (2001) Selection and accumulation of somatic mutations in children treated for leukemia. Leukemia 15(12):1898-1905
Ballinger SW, Judice SA, Nicklas JA, Albertini RJ, O'Neill, JP (2002) DNA Sequence Analysis of Interlocus Recombination Between the human T-Cell Receptor Gamma Variable (GV) and Beta Diversity-Joining (BD/BJ) Sequences on chromosome 7 (Inversion 7). Environ and Mol Mutagenesis 40(2):85-92
Perera F, Hemminki K, Jedrychowski W, Whyatt R, Campbell U, Hsu Y, Santella R, Albertini R, O'Neill JP (2002) In utero DNA damage from environmental pollution is associated with somatic gene mutation in newborns. Cancer Epidemiol Biomarkers Prev 11(10):1134-1137
Albertini RJ, Sram RJ, Vacek PM, Lynch J, Nicklas JA, Boogaard PJ, Henderson RF, Swenberg JA, Tates AD, Ward Jr. JB, Wright M, (2002). Biomarker responses in 1,3-butadiene exposed Czech workers: A transitional epidemiological study. HEI Research Report No. 16, June 2003, Health Effects Institute, Boston, MA
Albertini RJ, Clewell H, Himmelstein MW, Morinello E, Olin S, Preston J, Scarano L, Smith M, Swenberg J, Tice R, Travis, C, (2003). The use of non-tumor data in cancer risk assessment: Reflections on benzene, butadiene and vinyl chloride. ILSI Risk Science Institute, Working Group on the Use of Non-tumor Data in Cancer Risk Assessment. Regulatory Toxicol and Pharmacol, 37:105-132.